ArticleDrug design, development and therapy2025

An Open-Label, Single and Multiple Dose Study to Evaluate the Pharmacokinetics and Safety of Fezolinetant in Healthy Chinese Female Subjects.

Yang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.